Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Simó Servat, Olga ^a,b   Hernández, Cristina ^a,b,c   Simó, Rafael ^a,b,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SOMATOSTATIN; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ADHESION PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANALYTIC METHOD; BLOOD EYE BARRIER; CYTOKINE PRODUCTION; DIABETIC RETINOPATHY; DRUG SAFETY; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; HUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEOMICS; RETINA DISEASE; RETINAL NEURODEGENERATION; REVIEW; RISK BENEFIT ANALYSIS; TRANSLATIONAL RESEARCH; VITRECTOMY; VITREORETINAL SURGERY; VITREOUS DISEASE; VITREOUS FLUID ANALYSIS; VITREOUS HEMORRHAGE; VITREOUS INFLAMMATION;

EID: 84867795023     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/872978     Document Type: Review

References (101)

1. Cheung N., Mitchell P., Wong T. Y., Diabetic retinopathy. The Lancet 2010 376 9735 124 136 2-s2.0-77955013602 10.1016/S0140-6736(09)62124-3
2. Chen E., Looman M., Laouri M., Gallagher M., Van Nuys K., Lakdawalla D., Fortuny J., Burden of illness of diabetic macular edema: literature review. Current Medical Research and Opinion 2010 26 7 1587 1597 2-s2.0-77953555650 10.1185/03007995.2010.482503
3. Lamoureux E. L., Wong T. Y., Diabetic retinopathy in 2011: further insights from new epidemiological studies and clinical trials. Diabetes Care 2011 34 4 1066 1067 2-s2.0-79956223912 10.2337/dc11-0225
4. Javitt J. C., Cost savings associated with detection and treatment of diabetic eye disease. PharmacoEconomics 1995 8 supplement 1 33 39 2-s2.0-0029456919
5. Pelletier E. M., Shim B., Ben-Joseph R., Caro J. J., Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis. PharmacoEconomics 2009 27 6 479 490 2-s2.0-68349109433 10.2165/00019053-200927060-00004
6. Heintz E., Wirehn A. B., Peebo B. B., Rosenqvist U., Levin L. Å., Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden. Diabetologia 2010 53 10 2147 2154 2-s2.0-77958048810 10.1007/s00125-010-1836-3
7. Mohamed Q., Gillies M. C., Wong T. Y., Management of diabetic retinopathy: a systematic review. JAMA 2007 298 8 902 916 2-s2.0-34548087845 10.1001/jama.298.8.902 (Pubitemid 47311296)
8. Simó R., Hernández C., Advances in the medical treatment of diabetic retinopathy. Diabetes Care 2009 32 8 1556 1562 2-s2.0-68149131545 10.2337/dc09-0565
9. Simó R., Hernández C., Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia 2008 51 9 1574 1580 2-s2.0-49349103253 10.1007/s00125-008-0989-9
10. Robinson R., Barathi V. A., Chaurasia S. S., Wong T. Y., Kern T. S., Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. DMM Disease Models and Mechanisms 2012 5 4 444 456 2-s2.0-84863490715 10.1242/dmm.009597
11. Ambati J., Chalam K. V., Chawala D. K., D'Angio C. T., Guillet E. G., Rose S. J., Vanderlinde R. E., Ambati B. K., Elevated γ -aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Archives of Ophthalmology 1997 115 9 1161 1166 2-s2.0-0030987654 (Pubitemid 27387953)
12. Simó R., Carrasco E., García-Ramírez M., Hernández C., Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Current Diabetes Reviews 2006 2 1 71 98 2-s2.0-33646527453 10.2174/157339906775473671 (Pubitemid 44082952)
13. Simó R., Hernández C., Growth factors in the diabetic eye. Frontiers in Diabetes 2010 20 109 123 2-s2.0-77649111245 10.1159/000262665
14. Carrasco E., Hernández C., Miralles A., Huguet P., Farrés J., Simó R., Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care 2007 30 11 2902 2908 2-s2.0-36048980250 10.2337/dc07-0332 (Pubitemid 350083143)
15. Garcia-Ramírez M., Hernández C., Villarroel M., Canals F., Alonso M. A., Fortuny R., Masmiquel L., Navarro A., García-Arumí J., Simó R., Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy. Diabetologia 2009 52 12 2633 2641 2-s2.0-70949094028 10.1007/s00125-009-1548-8
16. Antonetti D. A., Klwin R., Gardner T. W., Diabetic retinopathy. The New England Journal of Medicine 2012 13 1227 1239
17. Kern T. S., Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Experimental Diabetes Research 2007 2007 95103 2-s2.0-41149099068
18. Tang J., Kern T. S., Inflammation in diabetic retinopathy. Progress in Retinal and Eye Research 2011 30 5 343 358 2-s2.0-79960190061 10.1016/j.preteyeres.2011.05.002
19. Abu el-Asrar A. M., Role of inflammation in the pathogenesis of Diabetic Retinopathy. Middle East African Journal of Ophthalmology 2012 19 70 74
20. Guarda G., So A., Regulation of inflammasome activity. Immunology 2010 130 3 329 336 2-s2.0-77953488157 10.1111/j.1365-2567.2010.03283.x
21. Kowluru R. A., Odenbach S., Role of interleukin-1 β in the pathogenesis of diabetic retinopathy. British Journal of Ophthalmology 2004 88 10 1343 1347 2-s2.0-4744347272 10.1136/bjo.2003.038133 (Pubitemid 39312984)
22. Ludwig W., Strunk O., Westram R., ARB: a software environment for sequence data. Nucleic Acids Research 2004 32 4 1363 1371 2-s2.0-2542523843 10.1093/nar/gkh293 (Pubitemid 38854737)
23. Vincent J. A., Mohr S., Inhibition of caspase-1/interleukin-1 β signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes 2007 56 1 224 230 2-s2.0-33847048626 10.2337/db06-0427
24. Demircan N., Safran B. G., Soylu M., Ozcan A. A., Sizmaz S., Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye 2006 20 12 1366 1369 2-s2.0-33845546564 10.1038/sj.eye.6702138 (Pubitemid 44921137)
25. Patel J. I., Saleh G. M., Hykin P. G., Gregor Z. J., Cree I. A., Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy. Eye 2008 22 2 223 228 2-s2.0-39449133026 10.1038/sj.eye.6702584 (Pubitemid 351266462)
26. Posada D., jModelTest: phylogenetic model averaging. Molecular Biology and Evolution 2008 25 7 1253 1256 2-s2.0-45849154165 10.1093/molbev/msn083 (Pubitemid 351882013)
27. Hernández C., Segura R. M., Fonollosa A., Carrasco E., Francisco G., Simó R., Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Diabetic Medicine 2005 22 6 719 722 2-s2.0-20444425336 10.1111/j.1464-5491.2005. 01538.x (Pubitemid 40805892)
28. Hayasaka S., Zhang X. Y., Cui H. S., Yanagisawa S., Chi Z. L., Hayasaka Y., Shimada Y., Vitreous chemokines and Sho (Zheng in Chinese) of Chinese-Korean-Japanese medicine in patients with diabetic vitreoretinopathy. American Journal of Chinese Medicine 2006 34 4 537 543 2-s2.0-33749468110 10.1142/S0192415X06004077 (Pubitemid 44515274)
29. Murugeswari P., Shukla D., Rajendran A., Kim R., Namperumalsamy P., Muthukkaruppan V., Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease. Retina 2008 28 6 817 824 2-s2.0-47749107263 10.1097/IAE. 0b013e31816576d5
30. Taub D. D., Anver M., Oppenheim J. J., Longo D. L., Murphy W. J., T lymphocyte recruitment by interleukin-8 (IL-8): IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. The Journal of Clinical Investigation 1996 97 8 1931 1941 2-s2.0-0029921168 (Pubitemid 26129881)
31. Ghasemi H., Ghazanfari T., Yaraee R., Faghihzadeh S., Hassan Z. M., Roles of IL-8 in ocular inflammations: a review. Ocular Immunology and Inflammation 2011 19 6 401 412 2-s2.0-0025735612 10.3109/09273948.2011.618902
32. El-Ghrably I. A., Dua H. S., Orr G. M., Fischer D., Tighe P. J., Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. British Journal of Ophthalmology 2001 85 4 461 470 2-s2.0-0035062653 10.1136/bjo.85.4.461 (Pubitemid 32275629)
33. Abu El-Asrar A. M., Struyf S., Kangave D., Geboes K., Van Damme J., Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. European Cytokine Network 2006 17 3 155 165 2-s2.0-39049193307
34. Zhang W., Liu H., Al-Shabrawey M., Caldwell R., Caldwell R., Inflammation and diabetic retinal microvascular complications. Journal of Cardiovascular Disease Research 2011 2 2 96 103 2-s2.0-79960789572 10.4103/0975-3583.83035
35. Gharaee-Kermani M., Denholm E. M., Phan S. H., Costimulation of fibroblast collagen and transforming growth factor β 1 gene expression by monocyte chemoattractant protein-1 via specific receptors. The Journal of Biological Chemistry 1996 271 30 17779 17784 2-s2.0-0030014832 10.1074/jbc.271.30.17779 (Pubitemid 26250752)
36. Hong K. H., Ryu J., Han K. H., Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 2005 105 4 1405 1407 2-s2.0-13544266205 10.1182/blood-2004-08-3178 (Pubitemid 40223654)
37. Rangasamy S., McGuire P. G., Das A., Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East African Journal of Ophthalmology 2012 19 1 52 59 2-s2.0-0033407485 10.4103/0974-9233.92116
38. Elner S. G., Strieter R., Bian Z. M., Kunkel S., Mokhtarzaden L., Johnson M., Lukacs N., Elner V. M., Interferon-induced protein 10 and interleukin 8: C-X-C chemokines present in proliferative diabetic retinopathy. Archives of Ophthalmology 1998 116 12 1597 1601 2-s2.0-0032423826 (Pubitemid 29001955)
39. Suzuki Y., Nakazawa M., Suzuki K., Yamazaki H., Miyagawa Y., Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Japanese Journal of Ophthalmology 2011 55 3 256 263 2-s2.0-79960072567 10.1007/s10384-011-0004-8
40. Strieter R. M., Burdick M. D., Mestas J., Gomperts B., Keane M. P., Belperio J. A., Cancer CXC chemokine networks and tumour angiogenesis. European Journal of Cancer 2006 42 6 768 778 2-s2.0-33646472556 10.1016/j.ejca.2006.01. 006
41. Godessart N., Kunkel S. L., Chemokines in autoimmune disease. Current Opinion in Immunology 2001 13 6 670 675 2-s2.0-0035546057 10.1016/S0952-7915(01) 00277-1 (Pubitemid 33000160)
42. Lasagni L., Francalanci M., Annunziato F., Lazzeri E., Giannini S., Cosmi L., Sagrinati C., Mazzinghi B., Orlando C., Maggi E., Marra F., Romagnani S., Serio M., Romagnani P., An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. Journal of Experimental Medicine 2003 197 11 1537 1549 2-s2.0-12444260282 10.1084/jem.20021897 (Pubitemid 36682550)
43. Kelsen S. G., Aksoy M. O., Yang Y., Shahabuddin S., Litvin J., Safadi F., Rogers T. J., The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cells. American Journal of Physiology 2004 287 3 L584 L591 2-s2.0-4143061265 10.1152/ajplung.00453.2003 (Pubitemid 39095915)
44. Bodnar R. J., Yates C. C., Wells A., IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circulation Research 2006 98 5 617 625 2-s2.0-33645319035 10.1161/01.RES.0000209968.66606.10
45. Shiraha H., Glading A., Chou J., Jia Z., Wells A., Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Molecular and Cellular Biology 2002 22 8 2716 2727 2-s2.0-0036207773 10.1128/MCB.22.8.2716-2727.2002 (Pubitemid 34262992)
46. Petrai I., Rombouts K., Lasagni L., Annunziato F., Cosmi L., Romanelli R. G., Sagrinati C., Mazzinghi B., Pinzani M., Romagnani S., Romagnani P., Marra F., Activation of p38MAPK mediates the angiostatic effect of the chemokine receptor CXCR3-B. International Journal of Biochemistry and Cell Biology 2008 40 9 1764 1774 2-s2.0-44649146341 10.1016/j.biocel.2008.01.008
47. Bodnar R. J., Yates C. C., Rodgers M. E., Du X., Wells A., IP-10 induces dissociation of newly formed blood vessels. Journal of Cell Science 2009 122 12, part 2 2064 2077 2-s2.0-68949181600 10.1242/jcs.048793
48. Angiolillo A. L., Sgadari C., Taub D. D., Liao F., Farber J. M., Maheshwari S., Kleinman H. K., Reaman G. H., Tosato G., Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. Journal of Experimental Medicine 1995 182 1 155 162 2-s2.0-0029031790 10.1084/jem.182.1.155
49. Strieter R. M., Kunkel S. L., Arenberg D. A., Burdick M. D., Polverini P. J., Interferon γ -inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochemical and Biophysical Research Communications 1995 210 1 51 57 2-s2.0-0028989347 10.1006/bbrc.1995. 1626
50. Yates-Binder C. C., Rodgers M., Jaynes J., Wells A., Bodnar R. J., Turner T., An IP-10 (CXCL10)-derived peptide inhibits angiogenesis. PLoS ONE 2012 7 7 e40812 2-s2.0-63449111231 10.1371/journal.pone.0040812
51. Hatch H. M., Zheng D., Jorgensen M. L., Petersen B. E., SDF-1 α /CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning and Stem Cells 2002 4 4 339 351 2-s2.0-0036961904 (Pubitemid 36105802)
52. Butler J. M., Guthrie S. M., Koc M., Afzal A., Caballero S., Brooks H. L., Mames R. N., Segal M. S., Grant M. B., Scott E. W., SDF-1 is both necessary and sufficient to promote proliferative retinopathy. The Journal of Clinical Investigation 2005 115 1 86 93 2-s2.0-13744254861 10.1172/JCI200522869 (Pubitemid 40385508)
53. Grant M. B., Afzal A., Spoerri P., Pan H., Shaw L. C., Mames R. N., The role of growth factors in the pathogenesis of diabetic retinopathy. Expert Opinion on Investigational Drugs 2004 13 10 1275 1293 2-s2.0-5444258548 10.1517/13543784.13.10.1275 (Pubitemid 39359658)
54. El-Asrar A. M. A., Nawaz M. I., Kangave D., Geboes K., Ola M. S., Ahmad S., Al-Shabrawey M., High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. Molecular Vision 2011 17 1829 1838 2-s2.0-79960729070
55. Parameswaran N., Patial S., Tumor necrosis factor-a signaling in macrophages. Critical Reviews in Eukaryotic Gene Expression 2010 20 2 87 103 2-s2.0-79651471957
56. Kahn S. E., Hull R. L., Utzschneider K. M., Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006 444 7121 840 846 2-s2.0-33845881411 10.1038/nature05482 (Pubitemid 46024990)
57. Doganay S., Evereklioglu C., Er H., Türköz Y., Sevinç A., Mehmet N., Şavli H., Comparison of serum NO, TNF- α IL-1 β sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 2002 16 2 163 170 2-s2.0-0035984887 10.1038/sj.EYE. 6700095 (Pubitemid 34537693)
58. Aveleira C. A., Lin C. M., Abcouwer S. F., Ambrósio A. F., Antonetti D. A., TNF- α signals through PKC ζ /NF- κ B to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes 2010 59 11 2872 2882 2-s2.0-78049280268 10.2337/db09-1606
59. Kitaoka Y., Kitaoka Y., Kwong J. M. K., Ross-Cisneros F. N., Wang J., Rong K. T., Sadun A. A., Lam T. T., TNF- α -induced optic nerve degeneration and nuclear factor- κ B p65. Investigative Ophthalmology and Visual Science 2006 47 4 1448 1457 2-s2.0-33645959539 10.1167/iovs.05-0299 (Pubitemid 46780751)
60. Madigan M. G., Sadun A. A., Rao N. S., Dugel P. U., Tenhula W. N., Gill P. S., Tumor necrosis factor-alpha (TNF- α)-induced optic neuropathy in rabbits. Neurological Research 1996 18 2 176 184 2-s2.0-0029940541 (Pubitemid 26131920)
61. Joussen A. M., Poulaki V., Mitsiades N., Kirchhof B., Koizumi K., Döhmen S., Adamis A. P., Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. The FASEB Journal 2002 16 3 438 440 2-s2.0-0036517850
62. Mirshahi A., Hoehn R., Lorenz K., Kramann C., Baatz H., Anti-tumor necrosis factor alpha for retinal diseases: current knowledge and future concepts. Journal of Ophthalmic and Vision Research 2012 7 1 39 44
63. Joussen A. M., Murata T., Tsujikawa A., Kirchhof B., Bursell S. E., Adamis A. P., Leukocyte-mediated endothelial cell injury and death in the diabetic retina. American Journal of Pathology 2001 158 1 147 152 2-s2.0-0035139461 (Pubitemid 32096479)
64. Joussen A. M., Poulaki V., Le M. L., Koizumi K., Esser C., Janicki H., Schraermeyer U., Kociok N., Fauser S., Kirchhof B., Kern T. S., Adamis A. P., A central role for inflammation in the pathogenesis of diabetic retinopathy. The FASEB Journal 2004 18 12 1450 1452 2-s2.0-7044228789 10.1096/fj.03-1476fje (Pubitemid 39561611)
65. Tamura H., Miyamoto K., Kiryu J., Miyahara S., Katsuta H., Hirose F., Musashi K., Yoshimura N., Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Investigative Ophthalmology and Visual Science 2005 46 4 1440 1444 2-s2.0-18244391221 10.1167/iovs.04-0905 (Pubitemid 41685887)
66. Joussen A. M., Poulaki V., Mitsiades N., Cai W. Y., Suzuma I., Pak J., Ju S. T., Rook S. L., Esser P., Mitsiades C. S., Kirchhof B., Adamis A. P., Aiello L. P., Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. The FASEB Journal 2003 17 1 76 78 2-s2.0-0037271803
67. McLeod D. S., Lefer D. J., Merges C., Lutty G. A., Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. American Journal of Pathology 1995 147 3 642 653 2-s2.0-0029162588
68. Song H., Wang L., Hui Y., Expression of CD18 on the neutrophils of patients with diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 2007 245 1 24 31 2-s2.0-34248663234 10.1007/s00417-006-0379-2 (Pubitemid 46766726)
69. Kociok N., Radetzky S., Krohne T. U., Gavranic C., Liang Y., Semkova I., Joussen A. M., ICAM-1 depletion does not alter retinal vascular development in a model of oxygen-mediated neovascularization. Experimental Eye Research 2009 89 4 503 510 2-s2.0-69749091950 10.1016/j.exer.2009.05.005
70. Limb G. A., Hickman-Casey J., Hollifield R. D., Chignell A. H., Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Investigative Ophthalmology and Visual Science 1999 40 10 2453 2457 2-s2.0-0032846389 (Pubitemid 29418408)
71. Hernández C., Burgos R., Cantón A., García- Arumí J., Segura R. M., Simó R., Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study. Diabetes Care 2001 24 3 516 521 2-s2.0-0035092001 (Pubitemid 32198423)
72. Adamiec-Mroczek J., Oficjalska-Myczak J., Misiuk-Hojo M., Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: analysis of vitreous samples. Cytokine 2010 49 3 269 274 2-s2.0-75449101393 10.1016/j.cyto.2009.11.004
73. Murata M., Noda K., Fukuhara J., Kanda A., Kase S., Saito W., Ozawa Y., Mochizuki S., Kimura S., Mashima Y., Okada Y., Ishida S., Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy. Investigative Ophthalmology and Visual Science 2012 53 4055 4062
74. Noda K., Nakao S., Ishida S., Leukocyte adhesion molecules in diabetic retinopathy. Journal of Ophthalmology 2012 2012 6 279037 10.1155/2012/279037
75. Navaratna D., McGuire P. G., Menicucci G., Das A., Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes 2007 56 9 2380 2387 2-s2.0-34548397756 10.2337/db06-1694 (Pubitemid 47358245)
76. Cantón A., Martinez-Cáceres E. M., Hernández C., Espejo C., García-Arumí J., Simó R., CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy. A flow cytometric analysis. Archives of Ophthalmology 2004 122 5 743 749 2-s2.0-2342577419 10.1001/archopht.122.5.743 (Pubitemid 38596255)
77. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I. R., Schwartz M., Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nature Medicine 1999 5 1 49 55 2-s2.0-0033049143 10.1038/4734 (Pubitemid 29050998)
78. Schwartz M., T cell mediated neuroprotection is a physiological response to central nervous system insults. Journal of Molecular Medicine 2000 78 11 594 597 2-s2.0-0034469544 10.1007/s001090000172 (Pubitemid 32202073)
79. Moalem G., Gdalyahu A., Shani Y., Otten U., Lazarovici P., Cohen I. R., Schwartz M., Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. Journal of Autoimmunity 2000 15 3 331 345 2-s2.0-0033712614 10.1006/jaut.2000.0441
80. Wolf S. A., Fisher J., Bechmann I., Steiner B., Kwidzinski E., Nitsch R., Neuroprotection by T-cells depends on their subtype and activation state. Journal of Neuroimmunology 2002 133 1-2 72 80 2-s2.0-0036890955 10.1016/S0165-5728(02)00367-3 (Pubitemid 35350847)
81. Hernández C., Ortega F., García-Ramírez M., Villarroel M., Casado J., García-Pascual L., Fernández-Real J. M., Simó R., Lipopolysaccharide-binding protein and soluble CD14 in the vitreous fluid of patients with proliferative diabetic retinopathy. Retina 2010 30 2 345 352 2-s2.0-76749144651 10.1097/IAE.0b013e3181b7738b
82. Nakanishi T., Koyama R., Ikeda T., Shimizu A., Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole. Journal of Chromatography B 2002 776 1 89 100 2-s2.0-0037173964 10.1016/S1570-0232(02)00078-8 (Pubitemid 34804346)
83. Koyama R., Nakanishi T., Ikeda T., Shimizu A., Catalogue of soluble proteins in human vitreous humor by one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrospray ionization mass spectrometry including seven angiogenesis-regulating factors. Journal of Chromatography B 2003 792 1 5 21 2-s2.0-0038798778 10.1016/S1570-0232(03)00133-8 (Pubitemid 36773797)
84. Yamane K., Minamoto A., Yamashita H., Takamura H., Miyamoto-Myoken Y., Yoshizato K., Nabetani T., Tsugita A., Mishima H. K., Proteome analysis of human vitreous proteins. Molecular & Cellular Proteomics 2003 2 11 1177 1187 2-s2.0-2342608111
85. Wu C. W., Sauter J. L., Johnson P. K., Chen C. D., Olsen T. W., Identification and localization of major soluble vitreous proteins in human ocular tissue. American Journal of Ophthalmology 2004 137 4 655 661 2-s2.0-1842504331 10.1016/j.ajo.2003.11.009 (Pubitemid 38446679)
86. García-Ramírez M., Canals F., Hernández C., Colomé N., Ferrer C., Carrasco E., García-Arumí J., Simó R., Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. Diabetologia 2007 50 6 1294 1303 2-s2.0-34247877623 10.1007/s00125-007-0627-y (Pubitemid 46701542)
87. Kim T., Sang J. K., Kim K., Kang U. B., Lee C., Kyong S. P., Hyeong G. Y., Kim Y., Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients. Proteomics 2007 7 22 4203 4215 2-s2.0-36549073658 10.1002/pmic.200700745 (Pubitemid 350190291)
88. Gao B. B., Chen X., Timothy N., Aiello L. P., Feener E. P., Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. Journal of Proteome Research 2008 7 6 2516 2525 2-s2.0-49849090387 10.1021/pr800112g
89. Shitama T., Hayashi H., Noge S., Uchio E., Oshima K., Haniu H., Takemori N., Komori N., Matsumoto H., Proteome profiling of vitreoretinal diseases by cluster analysis. ProteomicsClinical Applications 2008 2 9 1265 1280 2-s2.0-53549115616 10.1002/prca.200800017
90. Ouchi M., West K., Crabb J. W., Kinoshita S., Kamei M., Proteomic analysis of vitreous from diabetic macular edema. Experimental Eye Research 2005 81 2 176 182 2-s2.0-23144445854 10.1016/j.exer.2005.01.020 (Pubitemid 41080099)
91. Gao B. B., Clermont A., Rook S., Fonda S. J., Srinivasan V. J., Wojtkowski M., Fujimoto J. G., Avery R. L., Arrigg P. G., Bursell S. E., Aiello L. P., Feener E. P., Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nature Medicine 2007 13 2 181 188 2-s2.0-33846991924 10.1038/nm1534
92. Hernández C., García-Ramírez M., Colomé N., Villarroel M., Corraliza L., García-Pacual L., Casado J., Canals F., Simó R., New pathogenic candidates for diabetic macular edema detected by proteomic analysis. Diabetes Care 2010 33 7 e92 2-s2.0-77958195989 10.2337/dc10-0232
93. Chen W., Lu H., Dutt K., Smith A., Hunt Margaret D., Hunt R. C., Expression of the protective proteins hemopexin and haptoglobin cells of the neural retina. Experimental Eye Research 1998 67 1 83 93 2-s2.0-0032128348 10.1006/exer.1998.0494 (Pubitemid 28364817)
94. Kapojos J. J., Van Den Berg A., Van Goor H., Te Loo M. W. M., Poelstra K., Borghuis T., Bakker W. W., Production of hemopexin by TNF- α stimulated human mesangial cells. Kidney International 2003 63 5 1681 1686 2-s2.0-0242669259 10.1046/j.1523-1755.2003.00907.x (Pubitemid 36513313)
95. Wilson A. S., Hobbs B. G., Shen W. Y., Speed T. P., Schmidt U., Begley C. G., Rakoczy P. E., Argon laser photocoagulation-induced modification of gene expression in the retina. Investigative Ophthalmology and Visual Science 2003 44 4 1426 1434 2-s2.0-0037377963 10.1167/iovs.02-0622 (Pubitemid 36378564)
96. Aiello L. P., Avery R. L., Arrigg P. G., Keyt B. A., Jampel H. D., Shah S. T., Pasquale L. R., Thieme H., Iwamoto M. A., Park J. E., Nguyen H. V., Aiello L. M., Ferrara N., King G. L., Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. The New England Journal of Medicine 1994 331 22 1480 1487 2-s2.0-0027942607 10.1056/NEJM199412013312203 (Pubitemid 24356306)
97. Simó R., Lecube A., Sararols L., García-Arumí J., Segura R. M., Casamitjana R., Hernández C., Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients. Possible role in the development of proliferative diabetic retinopathy. Diabetes Care 2002 25 12 2282 2286 2-s2.0-0037599913 10.2337/diacare.25.12.2282 (Pubitemid 41071041)
98. Simó R., Carrasco E., Fonollosa A., García-Arumí J., Casamitjana R., Hernández C., Deficit of somatostatin in the vitreous fluid of patients with diabetic macular edema. Diabetes Care 2007 30 3 725 727 2-s2.0-33847629710 10.2337/dc06-1345 (Pubitemid 46354362)
99. Hernández C., Carrasco E., Casamitjana R., Deulofeu R., García-Arumí J., Simó R., Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects. Diabetes Care 2005 28 8 1941 1947 2-s2.0-23044508458 10.2337/diacare.28.8.1941 (Pubitemid 41060967)
100. Hernández C., Simó R., Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice. Expert Opinion on Investigational Drugs 2007 16 8 1209 1226 2-s2.0-34548231059 10.1517/13543784.16.8.1209 (Pubitemid 47321566)
101. Barba I., Garcia-Ramírez M., Hernández C., Alonso M. A., Masmique L., García-Dorado D., Simó R., Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor. Investigative Ophthalmology and Visual Science 2010 51 9 4416 4421 2-s2.0-77957347840 10.1167/iovs.10-5348